| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 2.260 | 20100301, Scala E
| | 1.10 - Any allergy symptom, Diagnosed | 2014 | Sweden | IgE | 61 | 14.750 | 20140708, Forsberg A
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 1.040 | 20120528, Patelis A
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.900 | 20130912, Lacerda Araujo LM
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 17.860 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 4.700 | 20140331, Rockmann H
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 0.000 | 20111214, Zheng YW
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 1987 | Australia | IgE | 17 | 58.800 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2001 | Spain | SPT | 8 | 0.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 6.060 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Spain / Netherlands | IgE | 10 | 70.000 | 20080902, Jacobsen B
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | France | IgE | 72 | 33.330 | 20100818, Siret-Alatrista A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy | IgE | 46 | 52.170 | 20100716, DUrbano LE
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Spain | IgE | 30 | 90.000 | 20130404, Escudero C
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 1996 | Denmark | IgE | 34 | 32.300 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2011 | Italy | IgE | 25 | 86.360 | 20110505, Egger M
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 1994 | United States | IgE | 22 | 54.500 | | | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.270 | 20120528, Patelis A
| | 6.5 - Occupational Exposure | 2002 | Italy | IgE | 77 | 0.000 | | | 6.5 - Occupational Exposure | 2006 | Spain | IgE | 24 | 20.000 | 20060831, Quirce S
| | 6.5 - Occupational Exposure | 2006 | Spain | SPT | 24 | 27.000 | 20060831, Quirce S
| | 6.6 - Source Exposure | 2006 | Germany | IgE | 16 | 37.500 | 20060711, Lin J
|
|
Loading...
Gal d 2
